Heart Test Laboratories, Inc. (HSCS)

Market Cap	3.00M
Revenue (ttm)	18,600
Net Income (ttm)	-6.39M
Shares Out	655.62K
EPS (ttm)	-48.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	291,382
Open	3.850
Previous Close	3.740
Day's Range	3.800 - 4.620
52-Week Range	3.400 - 98.000
Beta	3.15
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2024

About HSCS

Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 15, 2022
• Employees: 12
• Stock Exchange: NASDAQ
• Ticker Symbol: HSCS

Financial Performance

In 2023, HSCS's revenue was $5,150, a decrease of -64.17% compared to the previous year's $14,373. Losses were -$6.35 million, 31.6% more than in 2022.